Correvio Pharma Corp. Other Income and Expense
Correvio Pharma Corp. reported Other Income and Expense of -$7.55 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2020-04-30
| Period end | Nonoperating Income (Expense) 12 month |
|---|---|
| 2019-12-31 | -$7.55M 20-F · filed 2020-04-30 |
| 2018-12-31 | $9.80M 20-F · filed 2020-04-30 |
| 2017-12-31 | -$6.47M 20-F · filed 2020-04-30 |
| 2016-12-31 | -$4.92M 20-F · filed 2018-04-30 |
| 2015-12-31 | -$2.39M 20-F · filed 2018-04-30 |
| 2014-12-31 | -$1.59M 40-F · filed 2016-03-29 |
| 2013-12-31 | $21.57M 40-F · filed 2015-03-27 |
| 2012-12-31 | $7.64M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | -$1.46M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | -$1.17M 20-F/A · filed 2013-04-18 |